Mandalay Venture Partners — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Nbryonbryo.com in 𝕏Nov 2025 · $10M

Nbryo develops reproductive biotechnology solutions for livestock breeding, specifically focused on cattle embryo production and assisted reproductive technologies to improve genetic outcomes and sustainability in the dairy and beef industries.

AgTechAI & Machine LearningBiotechClimate TechBeaudesert, AU

Kaye MurdochPaul Niven(Founder)

BoardMatthewEuan Murdoch(Chair)Richard(Chair)

Co-investorsQIC Ventures Tenacious Ventures AgriZeroNZ

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.